Cue Biopharma (CUE) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CUE Stock Alerts $1.74 -0.18 (-9.38%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Cue Biopharma Stock Price Performance5 Day Performance-18.31%1 Month Performance-1.97%3 Month Performance-25.32%6 Month Performance-24.68%Year-To-Date Performance-34.09%1 Year Performance-63.21% Receive CUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… CUE Stock Chart for Saturday, May, 11, 2024 CUE Chart by TradingView Cue Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$1.91$1.92+0.26%$1.98$1.84171,338 shs$93.15 million05/08/2024$2.18$1.91-12.39%$2.13$1.84261,072 shs$92.90 million05/07/2024$2.08$2.18+4.81%$2.20$2.08237,223 shs$106.04 million05/06/2024$2.13$2.08-2.35%$2.26$2.05319,285 shs$101.17 million05/03/2024$1.88$2.13+13.30%$2.19$1.87663,090 shs$103.60 million05/02/2024$1.91$1.88-1.31%$1.94$1.76226,091 shs$91.44 million Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$1.90$1.91+0.26%$1.97$1.60622,040 shs$92.66 million04/30/2024$1.42$1.90+33.80%$1.98$1.371.26 million shs$92.42 million04/29/2024$1.37$1.42+4.03%$1.48$1.38155,919 shs$69.07 million04/26/2024$1.41$1.37-3.19%$1.44$1.32263,686 shs$66.39 million04/25/2024$1.42$1.41-0.70%$1.42$1.30169,155 shs$68.59 million04/24/2024$1.50$1.42-5.33%$1.54$1.38319,351 shs$69.07 million04/23/2024$1.57$1.50-4.46%$1.60$1.49161,329 shs$72.96 million04/22/2024$1.56$1.57+0.64%$1.58$1.49181,252 shs$76.37 million04/19/2024$1.58$1.56-1.27%$1.61$1.52169,010 shs$75.88 million04/18/2024$1.63$1.58-3.07%$1.65$1.56169,208 shs$76.85 million04/17/2024$1.50$1.63+9.03%$1.64$1.50315,315 shs$79.28 million04/16/2024$1.60$1.50-6.27%$1.67$1.47286,850 shs$72.72 million04/15/2024$1.75$1.60-8.86%$1.77$1.57238,986 shs$77.59 million04/12/2024$1.76$1.75-0.57%$1.76$1.65343,510 shs$85.12 million04/11/2024$1.78$1.76-0.85%$1.85$1.66429,855 shs$85.61 million04/10/2024$1.90$1.78-6.58%$1.90$1.72244,354 shs$86.34 million04/09/2024$2.04$1.90-6.86%$1.96$1.81537,918 shs$92.42 million04/08/2024$1.85$2.04+10.27%$2.08$1.85448,706 shs$99.23 million04/05/2024$1.78$1.85+3.93%$1.85$1.75219,691 shs$89.98 million04/04/2024$1.77$1.78+0.56%$1.87$1.74233,925 shs$86.58 million04/03/2024$1.82$1.77-2.75%$1.84$1.74276,747 shs$86.09 million04/02/2024$1.90$1.82-4.21%$1.95$1.78235,803 shs$82.12 million04/01/2024$1.89$1.90+0.53%$1.94$1.82186,807 shs$85.73 million03/29/2024$1.89$1.89$1.94$1.85192,133 shs$85.28 million03/28/2024$1.84$1.89+2.72%$1.94$1.85192,115 shs$85.28 million03/27/2024$1.84$1.84$1.87$1.76199,224 shs$83.02 million03/26/2024$1.86$1.84-1.08%$1.92$1.81138,251 shs$83.03 million03/25/2024$1.90$1.86-2.11%$1.98$1.83187,551 shs$83.92 million03/22/2024$1.94$1.90-2.06%$1.99$1.87135,756 shs$85.73 million03/21/2024$1.98$1.94-2.02%$2.01$1.85222,909 shs$87.54 million03/20/2024$1.88$1.98+5.32%$1.99$1.79258,347 shs$89.34 million03/19/2024$1.99$1.88-5.53%$1.96$1.85305,392 shs$84.83 million03/18/2024$2.07$1.99-3.86%$2.08$1.98170,046 shs$89.79 million03/15/2024$2.03$2.07+1.97%$2.08$1.98349,069 shs$93.40 millionTech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.03/14/2024$2.15$2.03-5.58%$2.23$1.98332,949 shs$91.59 million03/13/2024$1.77$2.15+21.47%$2.20$1.95608,731 shs$97.01 million03/12/2024$1.90$1.77-6.84%$1.92$1.77244,798 shs$79.86 million03/11/2024$1.98$1.90-4.04%$2.04$1.90149,003 shs$85.73 million03/08/2024$1.97$1.98+0.51%$2.05$1.93169,941 shs$89.34 million03/07/2024$1.94$1.97+1.55%$2.02$1.88243,730 shs$88.89 million03/06/2024$1.90$1.94+2.11%$1.99$1.85203,878 shs$87.53 million03/05/2024$2.02$1.90-5.94%$2.06$1.86282,261 shs$85.73 million03/04/2024$2.11$2.02-4.27%$2.09$1.98198,619 shs$91.14 million03/01/2024$2.08$2.11+1.69%$2.23$2.08202,739 shs$95.20 million02/29/2024$2.12$2.08-2.12%$2.16$2.06159,424 shs$93.62 million02/28/2024$2.36$2.12-10.17%$2.36$2.10243,139 shs$95.65 million02/27/2024$2.12$2.36+11.32%$2.37$2.141.23 million shs$106.48 million02/26/2024$2.01$2.12+5.47%$2.16$1.98211,666 shs$95.65 million02/23/2024$2.04$2.01-1.47%$2.04$1.95320,458 shs$90.69 million02/22/2024$2.08$2.04-1.92%$2.12$2.00216,192 shs$92.05 million02/21/2024$2.08$2.08$2.13$2.00142,639 shs$93.85 million02/20/2024$2.19$2.08-5.02%$2.25$2.04323,933 shs$93.85 million02/19/2024$2.19$2.19$2.36$2.17228,400 shs$98.81 million02/16/2024$2.35$2.19-6.81%$2.36$2.17228,381 shs$98.81 million02/15/2024$2.23$2.35+5.62%$2.37$2.23190,953 shs$106.03 million02/14/2024$2.27$2.23-1.98%$2.35$2.20255,968 shs$100.39 million02/13/2024$2.55$2.27-10.98%$2.45$2.26303,034 shs$102.42 million02/12/2024$2.33$2.55+9.44%$2.58$2.25193,366 shs$115.06 million02/09/2024$2.35$2.33-0.85%$2.43$2.31226,956 shs$105.13 million Related Companies: Assertio Stock Price Chart Cyteir Therapeutics Stock Price Chart Allakos Stock Price Chart Citius Pharmaceuticals Stock Price Chart Genelux Stock Price Chart IO Biotech Stock Price Chart PMV Pharmaceuticals Stock Price Chart BeyondSpring Stock Price Chart Adagene Stock Price Chart Oramed Pharmaceuticals Stock Price Chart Receive CUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CUE) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.